Down-regulation of the tumor suppressor PTEN by the tumor necrosis factor-alpha/nuclear factor-kappaB (NF-kappaB)-inducing kinase/NF-kappaB pathway is linked to a default IkappaB-alpha autoregulatory loop. 2004

Sunghoon Kim, and Claire Domon-Dell, and Junghee Kang, and Dai H Chung, and Jean-Noel Freund, and B Mark Evers
Department of Surgery, The University of Texas Medical Branch, Galveston, Texas 77555-0536, USA.

The PTEN (phosphatase and tensin homolog deleted on chromosome ten) tumor suppressor gene affects multiple cellular processes including cell growth, proliferation, and cell migration by antagonizing phosphatidylinositol 3-kinase (PI3K). However, mechanisms by which PTEN expression is regulated have not been studied extensively. Similar to PTEN, tumor necrosis factor-alpha (TNF-alpha) affects a wide spectrum of diseases including inflammatory processes and cancer by acting as a mediator of apoptosis, inflammation, and immunity. In this study, we show that treatment of cancer cell lines with TNF-alpha decreases PTEN expression. In addition, overexpression of TNF-alpha downstream signaling targets, nuclear factor-kappaB (NF-kappaB)-inducing kinase (NIK) and p65 nuclear factor NF-kappaB, lowers PTEN expression, suggesting that TNF-alpha-induced down-regulation of PTEN is mediated through a TNF-alpha/NIK/NF-kappaB pathway. Down-regulation of PTEN by NIK/NF-kappaB results in activation of the PI3K/Akt pathway and augmentation of TNF-alpha-induced PI3K/Akt stimulation. Importantly, we demonstrate that this effect is associated with a lack of an inhibitor of kappaB (IkappaB)-alpha autoregulatory loop. Moreover, these findings suggest the interaction between PI3K/Akt and NF-kappaB via transcriptional regulation of PTEN and offer one possible explanation for increased tumorigenesis in systems in which NF-kappaB is chronically activated. In such a tumor system, these findings suggest a positive feedback loop whereby Akt activation of NF-kappaB further stimulates Akt via down-regulation of the PI3K inhibitor PTEN.

UI MeSH Term Description Entries
D010744 Phosphoric Monoester Hydrolases A group of hydrolases which catalyze the hydrolysis of monophosphoric esters with the production of one mole of orthophosphate. Phosphatase,Phosphatases,Phosphohydrolase,Phosphohydrolases,Phosphomonoesterase,Phosphomonoesterases,Phosphoric Monoester Hydrolase,Hydrolase, Phosphoric Monoester,Hydrolases, Phosphoric Monoester,Monoester Hydrolase, Phosphoric
D011518 Proto-Oncogene Proteins Products of proto-oncogenes. Normally they do not have oncogenic or transforming properties, but are involved in the regulation or differentiation of cell growth. They often have protein kinase activity. Cellular Proto-Oncogene Proteins,c-onc Proteins,Proto Oncogene Proteins, Cellular,Proto-Oncogene Products, Cellular,Cellular Proto Oncogene Proteins,Cellular Proto-Oncogene Products,Proto Oncogene Products, Cellular,Proto Oncogene Proteins,Proto-Oncogene Proteins, Cellular,c onc Proteins
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D005246 Feedback A mechanism of communication within a system in that the input signal generates an output response which returns to influence the continued activity or productivity of that system. Feedbacks
D006706 Homeostasis The processes whereby the internal environment of an organism tends to remain balanced and stable. Autoregulation
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000072000 NF-KappaB Inhibitor alpha An I-kappa B protein that inhibits the activity of dimeric NF-KAPPA B P50-REL complexes, sequesters transcription factor NF-kappaB as an inactive complex in the cytoplasm; and prevents NF-kappaB nuclear translocation and DNA binding. I Kappa B-alpha Protein,IKappaB-alpha,IKappaBalpha,Major Histocompatibility Complex Enhancer-Binding Protein MAD3,p40 Protein (IKappaB-alpha),I Kappa B alpha Protein,IKappaB alpha,Inhibitor alpha, NF-KappaB,Major Histocompatibility Complex Enhancer Binding Protein MAD3,NF KappaB Inhibitor alpha,alpha, NF-KappaB Inhibitor
D000097782 NF-kappaB-Inducing Kinase A protein serine-threonine kinase that catalyzes the activation of canonical and non-canonical NF-kappaB pathways. MAP3K14 Kinase,Mitogen-Activated Protein Kinase Kinase Kinase 14,NF-kappa B Kinase,NF-kappa-B-Inducing Kinase (NIK),NFkB Kinase,NIK Protein,Nuclear Factor kappa B Kinase,B Kinase, NF-kappa,Kinase, MAP3K14,Kinase, NF-kappa B,Kinase, NF-kappaB-Inducing,Kinase, NFkB,Mitogen Activated Protein Kinase Kinase Kinase 14,NF kappa B Kinase,NF kappaB Inducing Kinase,Protein, NIK
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA

Related Publications

Sunghoon Kim, and Claire Domon-Dell, and Junghee Kang, and Dai H Chung, and Jean-Noel Freund, and B Mark Evers
March 2001, The Journal of experimental medicine,
Sunghoon Kim, and Claire Domon-Dell, and Junghee Kang, and Dai H Chung, and Jean-Noel Freund, and B Mark Evers
May 1996, The Journal of biological chemistry,
Sunghoon Kim, and Claire Domon-Dell, and Junghee Kang, and Dai H Chung, and Jean-Noel Freund, and B Mark Evers
April 2002, Shock (Augusta, Ga.),
Sunghoon Kim, and Claire Domon-Dell, and Junghee Kang, and Dai H Chung, and Jean-Noel Freund, and B Mark Evers
October 2007, The Journal of biological chemistry,
Sunghoon Kim, and Claire Domon-Dell, and Junghee Kang, and Dai H Chung, and Jean-Noel Freund, and B Mark Evers
June 2004, The Journal of biological chemistry,
Sunghoon Kim, and Claire Domon-Dell, and Junghee Kang, and Dai H Chung, and Jean-Noel Freund, and B Mark Evers
July 2011, The Journal of biological chemistry,
Sunghoon Kim, and Claire Domon-Dell, and Junghee Kang, and Dai H Chung, and Jean-Noel Freund, and B Mark Evers
September 2003, The Journal of biological chemistry,
Sunghoon Kim, and Claire Domon-Dell, and Junghee Kang, and Dai H Chung, and Jean-Noel Freund, and B Mark Evers
December 2005, Biochimica et biophysica acta,
Sunghoon Kim, and Claire Domon-Dell, and Junghee Kang, and Dai H Chung, and Jean-Noel Freund, and B Mark Evers
April 2002, American journal of respiratory and critical care medicine,
Sunghoon Kim, and Claire Domon-Dell, and Junghee Kang, and Dai H Chung, and Jean-Noel Freund, and B Mark Evers
March 2001, Oncogene,
Copied contents to your clipboard!